Williams David Solomon III Buys Shares of AHCO
Insider Williams David Solomon III purchased 18,999 shares of AHCO.
Key Points
- Williams David Solomon III bought 18,999 shares of AHCO on June 24, 2026.
- Shares of AHCO were trading at $10.18 on Saturday.
- Analysts from RBC Capital, Canaccord Genuity, and UBS maintain a 'buy' rating on AHCO with price targets ranging from $12 to $16.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Williams David Solomon III recently bought 18,999 shares of AHCO on June 24, 2026. This insider transaction did not involve a planned purchase under a Rule 10b5-1 plan.
Insider Buying and Selling at AdaptHealth Corp.
On June 24, 2026, Williams David Solomon III purchased 18,999 shares of AHCO. Susan Weaver also bought the same number of shares on the same day. Earlier, on June 1, 2026, Russell Schuster III, AHCO's Chief Commercial Officer, sold 11,275 shares at an average price of $10.06 under a planned transaction. Daniel Edward McFadden, the Chief Operating Officer, bought 20,134 shares on May 27, 2026.
Other Institutional Activity in AHCO
Several institutional investors have been active in AHCO. OEP Capital Advisors, L.P. increased its holdings by 2,494,518 shares, bringing its total to 16,312,698 shares valued at about $194.1 million, marking an 18.1% increase. BlackRock, Inc. added 247,939 shares, ending with 15,939,953 shares worth approximately $189.7 million, an increase of 1.6%. Deerfield Management Company, L.P. maintained its position with 11,477,730 shares valued at $136.6 million. Reinhart Partners, LLC. added 1,981,198 shares, resulting in 10,081,983 shares valued at $120.0 million, a 24.5% increase. Meanwhile, FMR LLC boosted its holdings by 423,256 shares, ending with 8,054,691 shares worth around $95.9 million, a 5.5% increase.
AdaptHealth Corp. Stock Up 75.7%
Shares of AHCO traded at $10.18 on Saturday. The stock has seen various institutional activities, with significant changes in holdings by major funds. Analysts have maintained a positive outlook on the stock, as reflected in recent analyst reports.
$AHCO stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
Analysts continue to show confidence in AHCO. On May 11, 2026, RBC Capital maintained its 'buy' rating with a price target of $15. Canaccord Genuity and UBS also maintained their 'buy' ratings on May 6, 2026, with targets of $16 and $14, respectively. The consensus among analysts is a 'buy' rating, with an average price target reflecting potential upside.
Bottom Line
Williams David Solomon III's purchase of AHCO shares underscores ongoing insider interest in the company. Institutional investors have been actively adjusting their positions, indicating continued attention from major funds. Analysts remain optimistic, with consistent 'buy' ratings and favorable price targets. As always, it's important for investors to consider that insider transactions and institutional moves are backward-looking indicators.
Get AdaptHealth Corp. alerts
New 13F filings, insider trades, and analyst moves on $AHCO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.